Skip to content
You are now leaving to visit

Akcea Announces Its Access and Distribution Strategy for TEGSEDI™ (inotersen)

Express Scripts’ Accredo® selected as specialty pharmacy for its expertise in providing timely access and support services for patients living with rare diseases BOSTON , Oct. 05, 2018 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc.